Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Albany Molecular Research, Inc.    AMRI

Delayed Quote. Delayed  - 02/12 03:59:48 pm
15.28 USD   -0.46%
02/09 ALBANY MOLECULA : AMRI : to Announce Fourth Quarter and Full Year 20..
02/09 NEMUS BIOSCIENC : Enters into Agreement with Albany Molecular Resear..
02/08 ALBANY MOLECULA : Amri appoints anthony j. maddaluna to board of dir..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ALBANY MOLECULAR RESEARCH,
05/03/16 Q1 2016 Earnings Release (Projected)
08/02/16 Interim 2016 Earnings Release (Projected)
11/02/16 Q3 2016 Earnings Release (Projected)
Past events on ALBANY MOLECULAR RESEARCH,
01/13/16 | 11:30am J.P. Morgan Health Care Conference - Q&A Session
01/13/16 | 11:00am JPMorgan Chase & Co., Inc. Health Care Conference
12/15/15 | 09:00am Acquisition of Whitehouse Laboratories by Albany Molecular Research, Inc. Call
11/18/15 | 12:20pm Jefferies Global Health Care Conference
Upcoming sector events for ALBANY MOLECULAR RESEARCH,
02/17/16 | 11:00am GENMAB A/S : FY 2015 Earnings Release
02/23/16 UNITED THERAPEUTICS CORPORATION : FY 2015 Earnings Release (Projected)
02/24/16 | 09:00am CELGENE CORPORATION : RBC Capital Markets’ Healthcare Conference
03/17/16 GENMAB A/S : Annual General Meeting
Annual publications
Previous yearNext Year
Annual results2012201320142015 (e)2016 (e)
Sales
Million $
Released
Forecast
Spread
227
216
5,0%
247
248
-0,39%
277
280
-1,3%

412

509
Operating income (EBITDA)
Million $
Released
Forecast
Spread
32,4
29,1
11%
48,7
46,5
4,6%
46,0
50,7
-9,3%

72,9

94,6
Operating profit (EBIT)
Million $
Released
Forecast
Spread
15,0
11,6
29%
32,8
30,8
6,5%
27,1
33,8
-20%

49,0

67,0
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread




-3,28
23,3
-114%

20,7

41,1
EPS
 $
Released
Forecast
Spread







0,18

1,11
Announcement Date02/12/201302/12/201402/12/2015

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ1
2015
Q2
2015
Q3
2015
Q4
2015 (e)
Q1
2016 (e)
Sales
Million $
Released
Forecast
Spread
81,8
81,5
0,39%
89,5
85,0
5,4%
105
95,2
9,9%

133

115
Operating income (EBITDA)
Million $
Released
Forecast
Spread
14,5
15,0
-3,2%
16,5
15,3
7,8%
16,5
15,3
8,3%

29,1

23,5
Operating profit (EBIT)
Million $
Released
Forecast
Spread
9,57
9,00
6,3%
12,1
9,55
26%
10,7
8,75
22%

21,6

16,5
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
-2,22
5,05
-144%
2,31
5,35
-57%
-4,17
3,80
-210%

11,8

7,90
EPS
 $
Released
Forecast
Spread
-0,07
0,16
-145%
0,07
0,18
-61%
-0,12
0,09
-233%

0,29


Announcement Date05/05/201508/04/201511/05/2015

© 2016 Thomson Reuters
© 2016 Factset
Advertisement
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise